about
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technol...
Read More
282.54
9.50
(3.48%)
1.0M
XNAS Volume
XNAS 05 Oct, 2026 11:49 AM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Illumina Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..